Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Neopterin is an emerging immunological marker for psychiatric disorders.
• The dexamethasone suppression test (DST) is used to assess HPA axis function.
• Posttraumatic stress disorder (PTSD) is a complex psychiatric condition with potential neuroendocrine and immune system alterations.

Purpose of the Study:

• To investigate the association between the DST, neopterin levels, and PTSD.
• To explore the relationship between illness duration, clinical severity, and neuroendocrine markers in PTSD patients.

Main Methods:

• The study included 14 patients with PTSD and 14 healthy controls.
• Participants underwent a clinical evaluation, DST, and measurements of cortisol and neopterin levels.
• PTSD symptom severity was assessed using the Clinician Administered PTSD Scale (CAPS).

Main Results:

• PTSD patients exhibited significantly higher DST nonsuppression compared to controls.
• A positive correlation was observed between illness duration and CAPS scores, basal cortisol, and postdexamethasone cortisol levels.
• Mean neopterin levels were significantly lower in PTSD patients both before and after the DST.

Conclusions:

• PTSD is associated with significant DST nonsuppression.
• Lower neopterin levels in PTSD patients suggest a potential role for this marker in the disorder.
• These findings highlight the interplay between the immune system, HPA axis, and PTSD pathophysiology.